Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Bucks County Business News

Windtree Therapeutics
Regional

Windtree Therapeutics Begins SEISMiC C Trial for Advanced Cardiogenic Shock

October 31, 2024October 30, 2024 - by Timothy Alexander

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has initiated patient enrollment for its SEISMiC C trial, targeting SCAI Stage C cardiogenic shock. This trial marks a pivotal step in …

Windtree Therapeutics Begins SEISMiC C Trial for Advanced Cardiogenic Shock Read More

Savara
Regional

Savara Inc. Shines Spotlight on Rare Lung Disease in New TV Feature

October 30, 2024October 28, 2024 - by Timothy Alexander

LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) recently featured in a new episode of The Balancing Act® on Lifetime TV, focusing on autoimmune Pulmonary Alveolar Proteinosis (aPAP). This episode, part …

Savara Inc. Shines Spotlight on Rare Lung Disease in New TV Feature Read More
CORA Group
Regional

Survey Reveals Loyalty and Rewards Drive Credit Card Choices Among Americans

October 25, 2024October 24, 2024 - by Timothy Alexander

WARMINSTER, PA — CORA Group, part of Jonas Software under Constellation Software Inc., has released the results of a recent survey conducted by The Harris Poll, shedding light on American …

Survey Reveals Loyalty and Rewards Drive Credit Card Choices Among Americans Read More

Aprea Therapeutics
Regional

Aprea Therapeutics Presents Promising Safety Data for WEE1 Inhibitor at International Symposium

October 25, 2024October 24, 2024 - by Timothy Alexander

DOYLESTOWN, PA — Aprea Therapeutics, Inc. (Nasdaq: APRE) recently showcased preliminary safety results for its WEE1 inhibitor, APR-1051, at the EORTC-NCI-AACR Symposium in Barcelona. This data comes from ACESOT-1051, a Phase …

Aprea Therapeutics Presents Promising Safety Data for WEE1 Inhibitor at International Symposium Read More
Windtree Therapeutics
Regional

Windtree Therapeutics Secures Global Patent Filings for Istaroxime

October 25, 2024October 24, 2024 - by Timothy Alexander

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced the completion of national phase filings for its istaroxime patent applications across key global markets, including the United States, Germany, …

Windtree Therapeutics Secures Global Patent Filings for Istaroxime Read More

Savara
Regional

Savara Inc. Rewards New Employees with Inducement Awards

October 23, 2024October 22, 2024 - by Timothy Alexander

LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA), a biopharmaceutical company, has announced the distribution of inducement awards to four new employees as part of their compensation package. These awards, granted on …

Savara Inc. Rewards New Employees with Inducement Awards Read More
Red Nucleus
Regional

Red Nucleus Secures Major Investment from THL Partners, Announces Leadership Shift

October 22, 2024October 21, 2024 - by Timothy Alexander

YARDLEY, PA — Red Nucleus, a prominent name in life sciences commercialization services, has announced a significant development with a majority investment from THL Partners, a private equity firm specializing …

Red Nucleus Secures Major Investment from THL Partners, Announces Leadership Shift Read More

314e Corporation
Regional

314e Strengthens Partnership to Revolutionize EHR Training with Jeeves Platform

October 20, 2024October 19, 2024 - by Timothy Alexander

YARDLEY, PA — 314e has announced an enhanced partnership with the KLAS Arch Collaborative, a coalition of healthcare organizations committed to improving Electronic Health Record (EHR) experiences. This collaboration aims to …

314e Strengthens Partnership to Revolutionize EHR Training with Jeeves Platform Read More
Windtree Therapeutics
Regional

Windtree Therapeutics Secures Patent for Heart Failure Treatment in Japan

October 18, 2024October 17, 2024 - by Timothy Alexander

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has announced a significant advancement in its cardiovascular portfolio with the issuance of a new patent for its drug istaroxime in Japan. The …

Windtree Therapeutics Secures Patent for Heart Failure Treatment in Japan Read More
Optinose
Regional

Optinose Grants Stock Options to Attract New Talent

October 17, 2024October 17, 2024 - by Timothy Alexander

YARDLEY, PA — Optinose, Inc. (NASDAQ: OPTN) has announced the allocation of non-qualified stock option awards to eight newly hired employees as part of their recruitment strategy. This move is designed …

Optinose Grants Stock Options to Attract New Talent Read More

Posts pagination

Previous 1 … 58 59 60 … 62 Next

Trending News

  • SAMHSA Opens $40 Million in Grants to Expand Addiction and Mental Health Programs

  • FDA Expands OTC Glucose Monitor Access to Children

  • HHS Launches Federal Elder Justice Plan to Combat Scams

  • Keystone State ChalleNGe Academy Graduates 56 Cadets in Latest Class

  • North Coventry Township: Where Every Century Left Something Behind

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Older man and woman

HHS Launches Federal Elder Justice Plan to Combat Scams

12 hours agoJune 14, 2026

Keystone State ChalleNGe Academy

Keystone State ChalleNGe Academy Graduates 56 Cadets in Latest Class

12 hours ago21 hours ago

Department of Veterans Affairs

VA Cuts Claims Backlog as Disability Decisions Accelerate

15 hours agoJune 14, 2026

Copyright © 2026 MyChesCo.